Cordlife

Singapore, Singapore Founded: 2001 • Age: 25 yrs
Cordlife is engaged in cord blood banking and diagnostics.
Request Access

About Cordlife

Cordlife is a company based in Singapore (Singapore) founded in 2001. It operates as a Subscription Services, and Professional Services. Cordlife has raised $7 million across 1 funding round from investors including Rothschild, APC Investors and UOB Venture Management. Cordlife has completed 1 acquisition, including StemLife. Cordlife offers products and services including Cord Blood Banking, Cord Lining Banking, Cord Tissue Banking, Non-Invasive Prenatal Testing, and Newborn Metabolic Screening. Cordlife operates in a competitive market with competitors including LifeCell, ViaCord, Calmark, Esperite and Cordlife India, among others.

  • Headquarter Singapore, Singapore
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cordlife Group Limited
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
    $20.28 M (USD)
    -50.39
    as on Dec 31, 2024
  • Net Profit
    $-13.85 M (USD)
    -635.99
    as on Dec 31, 2024
  • EBITDA
    $-14.81 M (USD)
    -765.24
    as on Dec 31, 2024
  • Total Equity Funding
    $7 M (USD)

    in 1 rounds

  • Latest Funding Round
    $7 M (USD), Series B

    Nov 04, 2003

  • Investors
    Rothschild

    & 2 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Cordlife

Cordlife is a publicly listed company on the SGX with ticker symbol P8A in Singapore, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: SGX · Ticker: P8A . Sector: Health services · Singapore

Products & Services of Cordlife

Cordlife offers a comprehensive portfolio of products and services, including Cord Blood Banking, Cord Lining Banking, Cord Tissue Banking, Non-Invasive Prenatal Testing, and Newborn Metabolic Screening. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Cord blood is stored for future medical use.

Cord lining is preserved for potential therapeutic applications.

Cord tissue is banked for future regenerative treatments.

Prenatal testing is offered for early health insights.

Metabolic screening is provided for newborn health checks.

People of Cordlife
Headcount 500-1000
Employee Profiles 9
Employee Profiles
People
Dang Vinh Do
Deputy Laboratory And Technical Director
People
Prosanto Kumar Chowdhury
Laboratory Director
People
Kevin K.w. Chik
Medical Director
People
Chiew Yoke Fong
Medical Director

Unlock access to complete

Funding Insights of Cordlife

Cordlife has successfully raised a total of $7M through 1 strategic funding round. The most recent funding activity was a Series B round of $7 million completed in November 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series B — $7.0M
  • First Round

    (04 Nov 2003)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2003 Amount Series B - Cordlife Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cordlife

Cordlife has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Rothschild, APC Investors and UOB Venture Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Limited information is provided about UOB Venture Management.
Founded Year Domain Location
Manages diversified investment portfolios across multiple asset classes for clients.
Founded Year Domain Location
Global investment banking services are provided worldwide.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cordlife

Cordlife has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include StemLife. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Cord blood and tissue banking, plus genetic testing, is provided.
2001
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Cordlife

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cordlife Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cordlife

Cordlife operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LifeCell, ViaCord, Calmark, Esperite and Cordlife India, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
LifeCell is engaged in cord blood banking services.
domain founded_year HQ Location
Provider of services for cord blood and stem cell banking
domain founded_year HQ Location
Point-of-care diagnostics for neonatal care are developed.
domain founded_year HQ Location
Umbilical cord blood stem cells are collected, processed, and stored.
domain founded_year HQ Location
Offers stem cell banking services for cord blood and cord lining storage globally.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cordlife

Frequently Asked Questions about Cordlife

When was Cordlife founded?

Cordlife was founded in 2001 and raised its 1st funding round 2 years after it was founded.

Where is Cordlife located?

Cordlife is headquartered in Singapore, Singapore.

Is Cordlife a funded company?

Cordlife is a funded company, having raised a total of $7M across 1 funding round to date. The company's 1st funding round was a Series B of $7M, raised on Nov 04, 2003.

What is the annual revenue of Cordlife?

Annual revenue of Cordlife is $20.28M as on Dec 31, 2024.

What does Cordlife do?

Cordlife Group Limited is focused on safeguarding the well-being of mother and child through private cord blood banking and related healthcare services. Operating primarily in Asia, the company is recognized as a pioneer in stem cell banking with facilities in Singapore, Hong Kong, Indonesia, the Philippines, India, and Malaysia. A comprehensive suite of diagnostics services, including non-invasive prenatal testing and newborn metabolic screening, is provided alongside cord blood, lining, and tissue banking. Innovation and technological advancement are emphasized to ensure reliable healthcare solutions across its markets.

Who are the top competitors of Cordlife?

Cordlife's top competitors include LifeCell, ViaCord and InfanDx.

What products or services does Cordlife offer?

Cordlife offers Cord Blood Banking, Cord Lining Banking, Cord Tissue Banking, Non-Invasive Prenatal Testing, and Newborn Metabolic Screening.

Is Cordlife publicly traded?

Yes, Cordlife is publicly traded on SGX under the ticker symbol P8A.

How many acquisitions has Cordlife made?

Cordlife has made 1 acquisition, including StemLife.

Who are Cordlife's investors?

Cordlife has 3 investors. Key investors include Rothschild, APC Investors, and UOB Venture Management.

What is Cordlife's ticker symbol?

The ticker symbol of Cordlife is P8A on SGX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available